SOX13 and cholangiocarcinoma: As was depicted in Figure 1A, SOX13 was expressed remarkably higher in cholangiocarcinoma (CHOL), breast invasive carcinoma (BRCA), esophageal carcinoma (ESCA), etc. compared to normal tissues.